search
Back to results

Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment (TMS-fMRI)

Primary Purpose

Mild Cognitive Impairment

Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation (Sham)
Sponsored by
University of Arizona
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mild Cognitive Impairment focused on measuring Mild Cognitive Impairment, Transcranial Magnetic Stimulation

Eligibility Criteria

50 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 50-80 years
  • MCI clinical criteria: (a) self- or informant-reported cognitive complaint; (b) preserved independence in functional abilities; and (c) absence of dementia.
  • Objective cognitive impairment supported by the following measures of general cognitive function: (a) Mini-Mental State Exam (MMSE) 24-27 (inclusive); (b) Montreal Cognitive Assessment (MoCA) 18-26 (inclusive); or (c) Clinical Dementia Rating Scale score of 0.5.
  • Right handed
  • English speaking
  • Able to attend daily intervention (Monday-Friday) for 4 days
  • Not enrolled in another interventional study within 6 months prior to beginning this study

Exclusion Criteria:

  • Contraindications to transcranial magnetic stimulation (TMS) or magnetic resonance imaging (MRI)
  • Other neurological disorders (e.g. stroke, head injuries, or multiple sclerosis)
  • Untreated depression
  • Current cancer treatment or other medical problems that might independently affect cognitive function
  • Clinical Dementia Rating Scale score more than 1.0

Sites / Locations

  • Bioscience Research LaboratoryRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Active TBS-Sham TBS

Sham TBS-Active TBS

Arm Description

Active TBS in block one, Sham TBS in block two

Sham TBS in block one, Active TBS in block two

Outcomes

Primary Outcome Measures

Brain imaging data
The investigators will acquire MRI images to measure structural and functional connectivity, respectively.
Correction rate in memory association recall
Memory tasks will be implemented and measure the correct rate to assess memory function.

Secondary Outcome Measures

Brain imaging data
The investigators will acquire MRI images to measure structural and functional connectivity, respectively.
Correction rate in memory association recall
Memory tasks will be implemented and measure the correct rate to assess memory function.

Full Information

First Posted
August 16, 2022
Last Updated
May 19, 2023
Sponsor
University of Arizona
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05515952
Brief Title
Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment
Acronym
TMS-fMRI
Official Title
Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2022 (Actual)
Primary Completion Date
March 31, 2024 (Anticipated)
Study Completion Date
March 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Arizona
Collaborators
National Institute on Aging (NIA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Emerging evidence indicates that dysfunction of hippocampal synaptic plasticity, which precedes neuronal degeneration during the progression of Alzheimer's disease (AD), underlies the hallmark cognitive impairment. Although there are currently no effective disease modifying treatments for AD, recent preclinical studies in animal models of AD have suggested that repetitive transcranial magnetic stimulation (rTMS) promotes hippocampal synaptic plasticity and, ultimately, improves learning and memory abilities. Interleaved TBS-MRI is a paradigm, which allows the investigators to study human brain functionality with real-time MRI, to better understand modulations of brain activity in response to the non-invasive brain stimulation, TBS. The interleaved TBSfMRI paradigm can more accurately estimated the immediate brain activity compared to the offline TBS-MRI studies in which TBS is applied outside the MRI. With this interleaved TBS-MRI approach, the investigators will be able to measure immediate changes in targeted brain activity, such as hippocampus activation, following each TBS session. This approach has created the unprecedented potential enabling the investigators to model the dose-dependent effects of TBS more accurately on brain function.
Detailed Description
The overarching goal of this proposed project is to maximize TBS effects to non-invasive spaced TBS in MCI. For the comparison, the investigators will include cognitively normal adults. There will be a screening session plus three consecutive days including baseline outcome measures on Day 1, TMS interventions and outcome measures on Day 2, and follow-up measurements on Day 3. In this project, on Day 2, participants will receive three TBS blocks inside the MRI scanner with each TBS block separated by 30-90 minutes to enhance the possibility of maximizing the TBS effect. This will be repeated in two blocks, each with a different TMS protocol. The protocols will be in randomized order.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mild Cognitive Impairment
Keywords
Mild Cognitive Impairment, Transcranial Magnetic Stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
19 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active TBS-Sham TBS
Arm Type
Other
Arm Description
Active TBS in block one, Sham TBS in block two
Arm Title
Sham TBS-Active TBS
Arm Type
Other
Arm Description
Sham TBS in block one, Active TBS in block two
Intervention Type
Device
Intervention Name(s)
Transcranial Magnetic Stimulation
Intervention Description
TMS is a non-invasive brain stimulation technique. The primary aim of the study will be to verify the deliverability of the TMS effect on the hippocampus and determine which stimulation protocol is more beneficial to each participant.
Intervention Type
Device
Intervention Name(s)
Transcranial Magnetic Stimulation (Sham)
Intervention Description
TMS is a non-invasive brain stimulation technique. The primary aim of the study will be to verify the deliverability of the TMS effect on the hippocampus and determine which stimulation protocol is more beneficial to each participant. For sham, the side of the coil that does not deliver pulses will be used.
Primary Outcome Measure Information:
Title
Brain imaging data
Description
The investigators will acquire MRI images to measure structural and functional connectivity, respectively.
Time Frame
Baseline
Title
Correction rate in memory association recall
Description
Memory tasks will be implemented and measure the correct rate to assess memory function.
Time Frame
Baseline
Secondary Outcome Measure Information:
Title
Brain imaging data
Description
The investigators will acquire MRI images to measure structural and functional connectivity, respectively.
Time Frame
immediately after and 24 hours after intervention
Title
Correction rate in memory association recall
Description
Memory tasks will be implemented and measure the correct rate to assess memory function.
Time Frame
immediately after and 24 hours after intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 50-80 years MCI clinical criteria: (a) self- or informant-reported cognitive complaint; (b) preserved independence in functional abilities; and (c) absence of dementia. Objective cognitive impairment supported by the following measures of general cognitive function: (a) Mini-Mental State Exam (MMSE) 24-27 (inclusive); (b) Montreal Cognitive Assessment (MoCA) 18-26 (inclusive); or (c) Clinical Dementia Rating Scale score of 0.5. Right handed English speaking Able to attend daily intervention (Monday-Friday) for 4 days Not enrolled in another interventional study within 6 months prior to beginning this study Exclusion Criteria: Contraindications to transcranial magnetic stimulation (TMS) or magnetic resonance imaging (MRI) Other neurological disorders (e.g. stroke, head injuries, or multiple sclerosis) Untreated depression Current cancer treatment or other medical problems that might independently affect cognitive function Clinical Dementia Rating Scale score more than 1.0
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lisbeth Haaheim
Phone
7853122110
Email
lhaaheim@arizona.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Yilin Liu
Email
yilin9@arizona.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ying-hui Chou, ScD
Organizational Affiliation
University of Arizona
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bioscience Research Laboratory
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85719
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lisbeth Haaheim
Email
tms-lab@list.arizona.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment

We'll reach out to this number within 24 hrs